[Table/Fig-3]:
Serum AMH levels in study group-IA (Prechemotherapy) and study group-IB (Postchemotherapy). (HS= Highly Significant)
| GROUP | AMH (ng/mL) |
|---|---|
| Study Group (IA) | 1.67 ± 0.44 |
| Study Group (IB) | 1.03 ± 0.25 |
| p-value | <0.001 |
| Significance | HS |
Serum AMH levels in study group-IA (Prechemotherapy) and study group-IB (Postchemotherapy). (HS= Highly Significant)
| GROUP | AMH (ng/mL) |
|---|---|
| Study Group (IA) | 1.67 ± 0.44 |
| Study Group (IB) | 1.03 ± 0.25 |
| p-value | <0.001 |
| Significance | HS |